In this study, we performed phenotypic and functional analyses on WT1-DCs pre-pulsed with WT1 peptides in low-adhesion culture maturation, and we evaluated active WT1-CTLs after WT1-DC administration in patients with cancer. This evidence concerns the gene WT1 and cancer.